BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 31828166)

  • 1. Effectiveness of Dose Adjustment of Insulin in Type 2 Diabetes among Hemodialysis Patients with End-Stage Renal Disease: A Randomized Crossover Study.
    Singhsakul A; Supasyndh O; Satirapoj B
    J Diabetes Res; 2019; 2019():6923543. PubMed ID: 31828166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved glycemic control with once-weekly dulaglutide in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.
    Yajima T; Yajima K; Hayashi M; Takahashi H; Yasuda K
    J Diabetes Complications; 2018 Mar; 32(3):310-315. PubMed ID: 29366733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hemodialysis on plasma glucose profile and plasma level of liraglutide in patients with type 2 diabetes mellitus and end-stage renal disease: a pilot study.
    Osonoi T; Saito M; Tamasawa A; Ishida H; Tsujino D; Nishimura R; Utsunomiya K
    PLoS One; 2014; 9(12):e113468. PubMed ID: 25526642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day-to-day variation of insulin requirements of patients with type 2 diabetes and end-stage renal disease undergoing maintenance hemodialysis.
    Sobngwi E; Enoru S; Ashuntantang G; Azabji-Kenfack M; Dehayem M; Onana A; Biwole D; Kaze F; Gautier JF; Mbanya JC
    Diabetes Care; 2010 Jul; 33(7):1409-12. PubMed ID: 20215452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of teneligliptin in addition to insulin therapy in type 2 diabetes mellitus patients on hemodialysis evaluated by continuous glucose monitoring.
    Yajima T; Yajima K; Hayashi M; Takahashi H; Yasuda K
    Diabetes Res Clin Pract; 2016 Dec; 122():78-83. PubMed ID: 27810689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodialysis and effect of corrective measures to prevent hypoglycemia.
    Katla V; Khyalappa R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of basal insulin analogues on glucose variability in patients with type 2 diabetes undergoing renal replacement therapy for end-stage renal disease.
    Savu O; Elian V; Steriade O; Teodoru I; Mihut S; Tacu C; Covic A; Serafinceanu C
    Int Urol Nephrol; 2016 Feb; 48(2):265-70. PubMed ID: 26725077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term impact of chronic hemodialysis on glycemic control and serum lipids in insulin-treated type 2-diabetic patients.
    Loipl J; Schmekal B; Biesenbach G
    Ren Fail; 2005; 27(3):305-8. PubMed ID: 15957547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoglycemia in Hospitalized Hemodialysis Patients With Diabetes: An Observational Study.
    Gianchandani RY; Neupane S; Heung M
    J Diabetes Sci Technol; 2018 Jan; 12(1):33-38. PubMed ID: 29291650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of oral glyburide in subjects with non-insulin-dependent diabetes mellitus and renal failure.
    Brier ME; Bays H; Sloan R; Stalker DJ; Welshman I; Aronoff GR
    Am J Kidney Dis; 1997 Jun; 29(6):907-11. PubMed ID: 9186077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis.
    Bally L; Gubler P; Thabit H; Hartnell S; Ruan Y; Wilinska ME; Evans ML; Semmo M; Vogt B; Coll AP; Stettler C; Hovorka R
    Kidney Int; 2019 Sep; 96(3):593-596. PubMed ID: 31133457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of a Basal-Bolus Insulin Regimen on Metabolic Control and Risk of Hypoglycemia in Patients With Diabetes Undergoing Peritoneal Dialysis.
    Gómez AM; Vallejo S; Ardila F; Muñoz OM; Ruiz ÁJ; Sanabria M; Bunch A; Morros E; Kattah L; García-Jaramillo M; León-Vargas F
    J Diabetes Sci Technol; 2018 Jan; 12(1):129-135. PubMed ID: 28927285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Analog and Human Insulin in a European Hemodialysis Cohort With Type 2 Diabetes: Associations With Mortality, Hospitalization, MACE, and Hypoglycemia.
    Ebert T; Sattar N; Greig M; Lamina C; Froissart M; Eckardt KU; Floege J; Kronenberg F; Stenvinkel P; Wheeler DC; Fotheringham J
    Am J Kidney Dis; 2024 Jan; 83(1):18-27. PubMed ID: 37657634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term glycemic control measurements in diabetic patients receiving hemodialysis.
    Joy MS; Cefalu WT; Hogan SL; Nachman PH
    Am J Kidney Dis; 2002 Feb; 39(2):297-307. PubMed ID: 11840370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
    Uemura F; Okada Y; Torimoto K; Tanaka Y
    Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypoglycemia in diabetics on dialysis with poor glycemic control: hemodialysis versus continuous ambulatory peritoneal dialysis.
    Tzamaloukas AH; Murata GH; Eisenberg B; Murphy G; Avasthi PS
    Int J Artif Organs; 1992 Jul; 15(7):390-2. PubMed ID: 1516987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemia Risk Related to Double Dose Is Markedly Reduced with Basal Insulin Peglispro Versus Insulin Glargine in Patients with Type 2 Diabetes Mellitus in a Randomized Trial: IMAGINE 8.
    Harris C; Forst T; Heise T; Plum-Mörschel L; Watkins E; Zhang Q; Fan L; Garhyan P; Porksen N
    Diabetes Technol Ther; 2017 Aug; 19(8):463-470. PubMed ID: 28817342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
    Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
    Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrice-weekly insulin injection with nurse's support for diabetic hemodialysis patients having difficulty with self injection.
    Shoji T; Emoto M; Mori K; Morioka T; Fukumoto S; Takahashi T; Matsumoto A; Nishizawa Y; Inaba M
    Osaka City Med J; 2012 Jun; 58(1):35-8. PubMed ID: 23094512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The intriguing effects of time to glycemic goal in newly diagnosed type 2 diabetes after short-term intensive insulin therapy.
    Cheng L; Xu M; Lin X; Tang J; Qi Y; Wan Y; Pan X; Chen X; Ren M; Yan L
    Endocr J; 2016 Aug; 63(8):739-46. PubMed ID: 27334121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.